| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/14/2009 | US7560261 Nucleic acid sequences encoding CEL II endonuclease |
| 07/14/2009 | US7560259 Transferase for use as evaluative tool in diagnosing/prediciting cell proliferative, neurodegenerative and arsenic metabolism disorders |
| 07/14/2009 | US7560247 Nucleic acids encoding anti-IL-12 antibodies, and methods of production |
| 07/14/2009 | US7560112 Anti-il-6 antibodies, compositions, methods and uses |
| 07/14/2009 | US7560108 Anti-TNFα antibodies |
| 07/14/2009 | US7560106 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 07/14/2009 | US7560105 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses |
| 07/14/2009 | US7560104 For use as vaccines for in vivo immunotherapy |
| 07/14/2009 | US7560103 Administering hapten modified syngeneic human tumor cell substantially in a no growth phase and an adjuvant for therapy of cancer |
| 07/14/2009 | US7560102 Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease |
| 07/14/2009 | CA2562760C A new method of expanding cord blood cells |
| 07/14/2009 | CA2467558C Creation of tissue engineered female reproductive organs |
| 07/14/2009 | CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis |
| 07/09/2009 | WO2009086535A2 Systems and methods for forming patterned extracellular matrix materials |
| 07/09/2009 | WO2009086425A1 Methods for reprogramming cells to a pluripotent state and therapeutic applications related thereto |
| 07/09/2009 | WO2009086352A2 Cynomolgus toll-like receptor 3 |
| 07/09/2009 | WO2009086191A1 Protein-free gamete and embryo handling and culture media products |
| 07/09/2009 | WO2009086106A1 Use of podocan protein in treating cardiovascular diseases |
| 07/09/2009 | WO2009085969A2 Compositions and methods to promote implantation and engrafment of stem cells |
| 07/09/2009 | WO2009085935A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 07/09/2009 | WO2009085860A1 Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells |
| 07/09/2009 | WO2009085278A1 Methods and compositions for producing olefins |
| 07/09/2009 | WO2009085212A1 Methods for producing pluripotent stem cell-generated embryos, and animals derived therefrom |
| 07/09/2009 | WO2009085067A2 Boundary conditions for the arrangement of cells and tissues |
| 07/09/2009 | WO2009084671A1 Human anti-α9 integrin antibody |
| 07/09/2009 | WO2009084668A1 Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method |
| 07/09/2009 | WO2009084662A1 Medium for mammalian somatic cells and additive therefor |
| 07/09/2009 | WO2009084439A1 Lignan hydroxylase |
| 07/09/2009 | WO2009083755A1 Use of t cells expressing cd16 receptors for enhancing the antibody-dependent cellular cytotoxiciy (adcc) |
| 07/09/2009 | WO2009083502A1 Ddr1-mediated cell purification of pancreatic endocrine cells through their progenitors |
| 07/09/2009 | WO2009047270A3 B cell tolerance induction |
| 07/09/2009 | WO2009042215A3 Inhibition of dendritic cell-driven regulatory t cell activation and potentiation of tumor antigen-specific t cell responses by interleukin-15 and map kinase inhibitor |
| 07/09/2009 | WO2009015840A3 Polypeptide for targeting of neural cells |
| 07/09/2009 | WO2008151833A3 Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds |
| 07/09/2009 | WO2008141511A8 A HUMAN ANTI-TNFα MONOCLONAL ANTIBODY AND THE USE THEREOF |
| 07/09/2009 | WO2008056173A8 Pluripotent cells from the mammalian late epiblast layer |
| 07/09/2009 | WO2008052478A8 Grain incomplete filling gene (gif1) and uses thereof |
| 07/09/2009 | US20090178163 non-coding regulatory element polynucleotide molecules isolated from Zea mays useful for expressing transgenes in plants |
| 07/09/2009 | US20090178162 Stress-related polypeptides and uses therefor |
| 07/09/2009 | US20090178161 Method for directing nucleic acids to plastids |
| 07/09/2009 | US20090178159 Plants with altered root architecture, involving the rum1 gene, related constructs and methods |
| 07/09/2009 | US20090178156 Polynucleotides encoding carotenoid and apocartenoid biosynthetic pathway enzymes in coffee |
| 07/09/2009 | US20090178155 Tomato Hybrid TBF-11 |
| 07/09/2009 | US20090178153 G protein coupled receptors and uses thereof |
| 07/09/2009 | US20090178151 guinea pig DP receptor |
| 07/09/2009 | US20090178149 Polyamine Sensors and Methods of Using the Same |
| 07/09/2009 | US20090178146 Regulators of NFAT |
| 07/09/2009 | US20090176966 Natural IGM Antibodies and Inhibitors Thereof |
| 07/09/2009 | US20090176880 Methods for Culturing Human Lung Mast Cells and Uses Thereof |
| 07/09/2009 | US20090176822 Pyrrolidine inhibitors of iap |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | US20090176729 Method of treating neurodegenerative disease |
| 07/09/2009 | US20090176727 Double-stranded rna structures and constructs, and methods for generating and using the same |
| 07/09/2009 | US20090176714 METHOD OF REDUCING THE EFFECTS OF ABeta AND COMPOSITIONS THEREFORE |
| 07/09/2009 | US20090176710 Complex for transferring an anionic substance into a cell |
| 07/09/2009 | US20090176707 Human signal peptide-containing proteins |
| 07/09/2009 | US20090176706 Materials and methods for treatment of inflammatory and cell proliferation disorders |
| 07/09/2009 | US20090176705 Modular platform for targeted therapeutic delivery |
| 07/09/2009 | US20090176695 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090176694 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090176660 Engineered Baculoviruses and Their Use |
| 07/09/2009 | US20090176657 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds |
| 07/09/2009 | US20090176307 Compounds, Compositions and Methods |
| 07/09/2009 | US20090176306 Method of inducing differentiation from visceral preadipocyte to visceral adipocyte |
| 07/09/2009 | US20090176305 Compounds and methods for treating breast cancer and other diseases |
| 07/09/2009 | US20090176304 Method for in vivo, ex vivo and in vitro repair and regeneration of cartilage and collagen and bone remodeling |
| 07/09/2009 | US20090176303 Method and apparatus for propagating benthic marine invertebrates |
| 07/09/2009 | US20090176302 Modified Mite Allergen and Pharmaceutical uses Thereof |
| 07/09/2009 | US20090176275 Expression system, components thereof and methods of use |
| 07/09/2009 | US20090176274 Glycosylated mammalian ngal and use thereof |
| 07/09/2009 | US20090176272 Expression of nucleic acid sequences for production of biofuels and other products in algae and cyanobacteria |
| 07/09/2009 | US20090176271 Systems for Efficient Staining and Sorting of Populations of Cells |
| 07/09/2009 | US20090176269 Cell culture processes |
| 07/09/2009 | US20090176260 Double-fusion human embryonic stem cells, methods of making double-fusion human embryonic stem cells, triple-fusion human embryonic stem cells, methods of making triple-fusion human embryonic stem cells, and methods of monitoring double-fusion human embryonic stem cells and triple-fusion human embryonic stem cells |
| 07/09/2009 | US20090176254 Mammalian galanin receptors |
| 07/09/2009 | US20090176246 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 07/09/2009 | US20090176239 Single-molecule-format real-time bioluminescence imaging probe |
| 07/09/2009 | US20090176238 Cynomolgus Toll-Like Receptor 3 |
| 07/09/2009 | US20090176229 Methods and compositions for the identification of insect repellent compounds |
| 07/09/2009 | US20090176217 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 07/09/2009 | US20090176211 Fluorescent protein |
| 07/09/2009 | US20090176209 Selection |
| 07/09/2009 | US20090176205 Mutant proteins in the dna-binding domain of a telomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna |
| 07/09/2009 | US20090176202 Methods of Detecting Inhibitors of VIF-Mediated APOBEC3G Degradation and HIV |
| 07/09/2009 | US20090176200 Modified Human Hepatitis C Virus Genomic RNA That can be Autonomously Replicated |
| 07/09/2009 | US20090176003 Mutant delta-8 desaturase genes engineered by targeted mutagensis and their use in making polyunsaturated fatty acids |
| 07/09/2009 | US20090175931 Compositions and methods for modulating hemostasis |
| 07/09/2009 | US20090175927 Administration of cells and cellular extracts for rejuvenation |
| 07/09/2009 | US20090175923 Humanized anti-amyloid beta antibodies |
| 07/09/2009 | US20090175922 Three dimensional purified collagen matrices |
| 07/09/2009 | US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system |
| 07/09/2009 | US20090175910 Modifications of HIV Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 07/09/2009 | US20090175908 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175892 Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes |
| 07/09/2009 | US20090175890 Use of immature dendritic cells to silence antigen specific cd8+ t cell function |
| 07/09/2009 | US20090175889 Hiv vaccine |
| 07/09/2009 | US20090175887 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 07/09/2009 | US20090175886 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues |
| 07/09/2009 | US20090175881 Interleukin-17A specific immunoglobulin for use in prevention and treatment of inflammatory, autoimmune and proliferative disorders |